From chronorisk to chronotherapy, with focus on the cardiovascular system

From chronorisk to chronotherapy, with focus on the cardiovascular system

Автор: Cornelissen G., Beaty L.A., Gubin D., Siegelova J., Havelkova A., Otsuka K.

Журнал: Вестник Международной академии наук (Русская секция) @vestnik-rsias

Рубрика: Медико-биологические науки, науки о человеке

Статья в выпуске: 1, 2023 года.

Бесплатный доступ

An organism’s response to a given stimulus changes predictably depending on the time of its administration, due in large part to the endogenous circadian system. Such changes in susceptibility to a wide variety of stimuli led to the concept of chronorisk to reflect the hours of changing resistance to external agents. Chronorisk also constitutes the foundation for the fields of chronotherapy and chronopharmacology, as circadian rhythms affect all aspects of pharmacology, from absorption and distribution to metabolism and excretion. Recent advances in chronobiology indicated how circadian disruption relates to increased disease risk, and brought awareness about inter-individual disparities in circadian phase (approximated by chronotype). The principle of chronotherapy has evolved accordingly. New studies bring evidence for the merit of determining the optimal time to administer a given medication on a personal basis in preference to making general recommendations in terms of time of day. Accounting for the chronodiagnosis in recommending a time to treat, known as chronotheranostics, is one way to personalize chronotherapy, as illustrated for the case of blood pressure disorders. We present different approaches to chronotherapy and discuss the relative merits of several study designs for personalized chronotherapy.

Еще

Biorhythms, circadian rhythms, chronorisk, chronotherapy, chronoteranostics

Короткий адрес: https://sciup.org/143183256

IDR: 143183256

Список литературы From chronorisk to chronotherapy, with focus on the cardiovascular system

  • Halherg F. Chronobiology. Annu Rev Physiol 1969; 31: 675-725.
  • Halherg F, Cornelissen G, Otsuka K, Schwartzkopff O, Halherg J, Bakken F.F. Chronomics. Biomed & Pharmacother 2001; 55 (Suppl 1): 153s-190s.
  • Konopka RJ, Benzer S. Clock mutants of Drosophila melanogaster. Proc Natl Acad Sci USA 1971; 68(9): 2112-2116.
  • Ralph M.R, MenakerM. A mutation ofthe circadian system in golden hamsters. Science 1988; 241 (4870): 1225-1227.
  • Shearman L.P., Sriram S, Weaver D.R et al. Interacting molecular loops in the mammalian circadian clock. Science 2000; 288 (5468): 1013-1019.
  • Palm D, Uzoni A, Simon- F. et al. Evolutionary conservations, changes of circa-dian rhythms and their effect on circadian disturbances and therapeutic approaches. Neuroscience & Biobehavioral Reviews 2021; 128: 21-34.
  • Mieda M. The central circadian clock ofthe suprachiasmatic nucleus as an ensemble ofmultiple oscillatory neurons. Neuroscience Research 2020; 156: 24-31.
  • Kofuji P., Mure L.S., Massman L.J, Purrier N, Panda. S, Engeland W.C. Intrinsically photosensitive retinal ganglion cells (ipRGCs) are necessary for light entrainment of peripheral clocks. PLoS ONE 2016; 11 (12) e0168651.
  • AyyarV.S, SukumaranS. Circadian rhythms: influence on physiology, pharmacology, and therapeutic interventions. J Pharmacokinet Pharmacodyn 2021; 48 (3) 321-338.
  • Gekakis N., Stalcnis D, Nguyen H.B. et al. Role of the CLOCK protein in the mammalian circadian mechanism. Science 1998; 280 (5369): 1564—1569.
  • Lowrey P.L, Takahashi J.S. Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Annual Review of Genomics and Human Genetics 2004; 5: 407-441.
  • Cox K.H. and Takahashi J.S. Circadian clock genes and the transcriptional architecture of the clock mechanism. J Mol Endocrinol 2019; 63: R93-R102
  • Reppert S.M, Weaver D.R Coordination of circadian timing in mammals. Nature 2002; 418 (6901): 935-941.
  • Kawamoto T, Noshiro MM., Sato F. et al. A novel autofeedback loop ofDec1 transcription involved in circadian rhythm regulation. Biochem Biophys Res Commun 2004; 313 (1) 117-124.
  • Honma S, Kawamoto T, Takagi Y, Fujimoto K., Sato F, Noshiro MM., Kato Y., Honma K ec1 and Dec2 are regulators of the mammalian molecular clock. Nature 2002; 419 (6909): 841-844.
  • Vitaterna MM..H, Shimomura K., Jiang P. Genetics of circadian rhythms. Neurol Clin 2019; 37 (3) 487-504.
  • Halberg F, Drayer J.I.M, Cornelissen G., Weber M.A. Cardiovascular reference data base for recognizing circadian mesor- and amplitude-hypertension in apparently healthy men. Chronobiologia 1984; 11: 275-298.
  • Cornelissen G, Bakken E, Delmore P., ... Halberg F. From various kinds ofheart rate variability to chronocardiology. Am J Cardiol 1990; 66: 863-868.
  • Descovich G.C, Montalbet N., Kbhl J.F.W., Rimondi S., Halberg F., Ceredi C. Age and catecholamine rhythms. Chronobiologia 1974; 1: 163-171.
  • Prikryl P, Cornelissen G, Otsuka K., Halberg F. Plasma catecholamines: follow-up on 10-year study in health and cardiovascular disease. Biomed & Pharmacother 2005; 59 (Suppl 1): S180-S187.
  • Tofler G.H, Brezinski D, Schafer A.I. et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. New England Journal ofMedicine 1987; 316 (24) 1514-1518.
  • Agzamova R.T, Zaslavskaya R.M., Perepyolkin K.G., Halberg F., Teibloom MM. Circadian changes of the hemocoagulation indices in healthy persons. Bull Exp Biol Med 1993; 115: 452-455.
  • Tarquini B., Perfetto F, Tarquini R., Cornelissen G., Halberg F. Endothelin-1's chronome indicates diabetic and vascular disease chronorisk. Peptides 1997; 18: 119-132.
  • Orth-Gomer K, Halberg F, Sothern R, A^cerstedt T., Theorell T., Cornelissen G. The circadian rhythm ofventricular arrhythmias. In: Takahashi R, Halberg F, Walker C (Eds.) Toward Chronopharmacology, Proc. 8th IUPHAR Cong. and Sat Symposia, Nagasaki, July 27-28, 1981. Oxford/New York Pergamon Press; 1982. pp. 191-202.
  • Muller J.E, Stone P.H, Turi Z.G. et al. Orcadian variation in the frequency of onset ofacute myocardial infarction. N Engl J Med 1985; 313 (21) 1315-1322.
  • Twidale N, Taylor S, Heddle W.F., Ayres B.F., Tonkin AM. Morning increase in the time of onset of sustained ventricular tachycardia. The American Journal ofCardiology 1989; 64: 1204-1206.
  • Willich S.N, Goldberg R.J, Maclure MM., Perriello L., Muller J.E. Increased onset of sudden cardiac death in the first three hours after awakening. American Journal of Cardiology 1992; 70 (1) 65-68.
  • Cornelissen G, Tamura K, Tarquini B. et al. Differences in some circadian patterns of cardiac arrhythmia, myocardial infarction and other adverse vascular events. Chronobiologia 1994; 21: 79-88.
  • Elliot W.J. Circadian variation in the timing of stroke onset: a meta-analysis. Stroke 1998; 29 (5) 992-996.
  • Halberg F, BittnerJ.J., Gully R.J., AlbrechtP.G., Brackney E.L. 24-hour periodicity and audiogenic convulsions in I mice of various ages. Proc Soc Exp Biol Med (Maywood) 1955; 88: 169-173.
  • Halberg F, Johnson- E.A., Brown. BW., Bittner J.J. Susceptibility rhythm to E. coli endotoxin and bioassay. Proc Soc Exp Biol Med (Maywood) 1960; 103: 142-144.
  • HausE, HalbergF, loken M.K. Orcadian susceptibility-resistance cycle of bone marrow cells to whole-body X-irradiation in BALB/c mice. In: Scheving LE, Halberg F, Pauly JE (Eds.) Chronobiology: Proceedings of the International Society for the Study of Biological Rhythms, Little Rock, Arkansas, November 8-10, 1971. Stuttgart: Georg Thieme Publishers/Tokyo: Igaku Shoin Ltd; 1974. pp. 115-122
  • HalbergF, Stephens A.N. Susceptibility to ouabain and physiologic circadian periodicity. Proc Minn Acad Sci 1959; 27, 139-143.
  • Ertel R.J, Halberg F, Ungar F. Circadian system phase-dependent toxicity and other effects ofmethopyrapone (SU-4885) in mice. J Pharmacol Exp Ther1964; 146: 395-399.
  • HalbergF. Chronobiology and nutrition. Contemporary Nutrition 1983; 8: #9, 2 pp.
  • labecqueG, BelangerPM. Biological rhythms in the absorption, distribution, metabolism and excretion of drugs. Pharmacology & Therapeutics 1991; 52 (1): 95-107.
  • MMusiek E.S, Fitzgerald G.A. Molecular clocks in pharmacology. Handb Exp Pharmacol. 2013; 217 (217): 243-260.
  • Dallmann R, Brown S.A, Gachon F. Chronopharmacology: new insights and therapeutic implications. Annu Rev Pharmacol Toxicol 2014; 54: 339-361.
  • Zhang Y.K, Yeager RL, Klaassen C.D. Orcadian expression profiles of drug-processing genes and transcription factors in mouse liver. Drug Metab Dispos 2009; 37: 106-115.
  • Panda S., Antoch MM..P, Miller B.H. et al. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 2002; 109 (3): 307-320.
  • Gubin D. Chronotherapeutic approaches. In: Chronobiology and Chronomedicine: From Molecular and Cellular Mechanisms to Whole Body Interdigitating Networks. Cornelissen G, Hirota Y (Eds.) Royal Society of Chemistry 2023; in press.
  • Knapp M.S. Chronobiology and the kidney. In: Chronobiology and Chronomedicine: From Molecular and Cellular Mechanisms to Whole Body Interdigitating Networks. Cornelissen G, Hirota Y (Eds.) Royal Society of Chemistry 2023; in press.
  • Bicker J., Alves G., Falcao A., Fortuna A. Timing in drug absorption and disposition: The past, present, and future of chronopharmacokinetics. British Journal ofPharmacology 2020; 177 (10) 2215-2239.
  • Halberg F., Cornelissen G., Halberg E. et al. Chronobiology of human blood pressure. Medtronic Continuing Medical Education Seminars, 4th ed. Minneapolis: Medtronic Inc.; 1988. 242 pp.
  • Otsuka K., Cornelissen G, Halberg F. Chronomics and Continuous Ambulatory Blood Pressure Monitoring — Vascular Chronomics: From 7-Day/24-Hour to Lifelong Monitoring. Tokyo: Springer Japan, 2016, 870 + lxxv pp. 10.1007/9784-431-54631-3.
  • Halberg F., Cornelissen G., Otsuka K., Siegelova J., Fiser B., Dusek J., Homolka P., Sanchez de la Pena S., Singh R.B., BIOCOS project. Extended consensus on means and need to detect vascular variability disorders (VVDs) and vascular variability syndromes (VVSs). World Heart J 2010; 2 (4) 279-305.
  • Halberg F., Powell D., Otsuka K. et al. Diagnosing vascular variability anomalies, not only MESOR-hypertension. Am J Physiol Heart Circ Physiol 2013; 305: H279-H294.
  • Cornelissen G., Halberg F., Bakken E.E., et al. 100 or 30 years after Janeway or Bartter, Healthwatch helps avoid «flying blind». Biomed & Pharmacother 2004; 58 (Suppl 1) S69-S86.
  • Güllner H.G., Bartter F.C., Halberg F. Timing antihypertensive medication. The Lancet 1979; 314 (issue 8141; 8 Sept): 527.
  • Güllner H.G., Bartter F.C., Halberg F., Delea C. Circadian temperature and blood pressure rhythms guide timed optimization and gauge antimesorhyper-tensive prazosin effects. Chronobiologia 1979; 6: 105.
  • Watanabe Y., Beaty L., Otsuka K., Siegelova J., Cornelissen G. Lessons learned from longitudinal blood pressure monitoring. In: Cornelissen G, Siegelova J, Dobsak P (Eds.) Noninvasive Methods in Cardiology 2017. Masaryk University, Brno, Czech Republic 2017; 149-156.
  • Zaslavskaya R.M. Chronodiagnosis and Chronotherapy of Cardiovascular Diseases, 2nd ed. (English translation). Moscow: Medicina, 1993.
  • Cornelissen G., Zaslavskaya R.M., Kumagai Y., Romanov Y., Halberg F. Chronopharmacologic issues in space. J Clin Pharmacol 1994; 34: 543-551.
  • Cornelissen G., Halberg F., Prikryl P., Dankova E., Siegelova J., Dusek J, International Womb-to-Tomb Chronome Study Group. Prophylactic aspirin treatment: the merits of timing. JAMA 1991; 266: 3128-3129.
  • Raab F.J., Schaffer EM, GuiUaume-Cornelissen G., Halberg F. Interpreting vital sign profiles for maximizing patient safety during dental visits. JADA 1998; 129: 461-469.
  • Bingham C., Arbogast B., Cornelissen Guillaume G., Lee J.K, Halberg F. Inferential statistical methods for estimating and comparing cosinor parameters. Chronobiologia 1982; 9: 397-439.
  • Cornelissen G, Halberg F. Treatment with open eyes: markers--guided chronotheranostics. In: Youan BC (Ed.) Chronopharmaceutics: Science and Technology for Biological Rhythm-Guided Therapy and Prevention of Diseases. Hoboken, NJ: Wiley; 2009. pp. 257-323.
  • Hawkins D.M. Self-starting cusum charts for location and scale. The Statistician 1987; 36: 299-315.
  • Halberg F., Cornelissen G., Katinas G. et al. International BIOCOS Group. Chronobiology's progress: Part II, chronomics for an immediately applicable biomedicine. J Appl Biomed 2006; 4: 73-86.
  • Prikryl P., Cornelissen G., Neubauer J., Prikryl P. Jr., Karpisek Z., Watanabe Y., Otsuka K., Halberg F. Chronobiologically explored effects of telmisartan. Clin Exp Hypertens 2005; 2 & 3: 119-128.
  • Watanabe Y., Halberg F., Otsuka K., Cornelissen G. Toward a personalized chronotherapy of high blood pressure and a circadian overswing. Clin Exp Hypertens 2013; 35 (4) 257-266.
  • Cornelissen G., Beaty L.A., Siegelova J, Watanabe Y., Otsuka K, and Members of the Phoenix Study Group, for the Investigators of the Project on the BIOsphere and the COSMOS (BIOCOS). Comments on the 2018 ESC/ESH Consensus Blood Pressure Guidelines regarding the use of Ambulatory Blood Pressure Monitoring (ABPM). In: Cornelissen G., Siegelova J., Dobsak P. (Eds.) Noninvasive Methods in Cardiology 2018. Masaryk University, Brno, Czech Republic 2018; 15-31.
  • Whelton P.K., Carey R.M., Aronow W.S. et al. 2017 ACC/AHA/AAPA/ABC/ ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018; 71 (6) 1269-1324.
  • Verdecchia P., Angeli F., Mazzotta G., Garofoli MM., Ramundo E., Gentile G., Ambrosio G., Reboldi G. Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications. Hypertension 2012; 60 (1) 34-42.
  • Fagard RH., Thijs L., Staessen J.A. et al. Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension. J Hum Hypertens 2009; 23 (10) 645-653.
  • Cornelissen G., Halberg F., Otsuka K., Singh R.B. Separate cardiovascular disease risks: circadian hyper-amplitude-tension (CHAT) and an elevated pulse pressure. World Heart J 2008; 1 (3) 223-232.
  • Kim B.K., Kim Y.M., Lee Y., Lim Y.H., Shin J. A reverse dipping pattern predicts cardiovascular mortality in a clinical cohort. J Korean Med Sci 2013; 28 (10) 1468-1473.
  • Tadic MM., Cuspidi C., Celic V. et al. The prognostic effect ofcircadian blood pressure pattern on long-term cardiovascular outcome is independent of left ventricular remodeling. J Clin Med 2019; 8 (12) 2126.
  • AbdallaMM., Caughey M.C., TannerRM. etal. Associations ofblood pressure dipping patterns with left ventricular mass and left ventricular hypertrophy in blacks: The Jackson Heart Study. J Am Heart Assoc 2017; 6 (4) e004847.
  • Fujiwara T., Hoshide S., Kanegae H., Kario K. Prognostic value of a riser pattern of nighttime blood pressure in very elderly adults of >80 years: A general practice-based prospective SEARCH study. Am J Hypertens 2020; 33 (6): 520-527.
  • Tadic MM., Cuspidi C., Celic V. et al. The prognostic importance ofright ventricular remodeling and the circadian blood pressure pattern on the long-term cardiovascular outcome. J Hypertens 2020; 38 (8) 1525-1530.
  • Gavriilaki M., Anyfanti P, Nikolaidou B. et al. Nighttime dipping status and risk of cardiovascular events in patients with untreated hypertension: A systematic review and meta-analysis. J Clin Hypertens 2020; 22 (11): 1951 — 1959.
  • Jhee J.H, Nam B.Y., Lee C.J. et al. Soluble urokinase-type plasminogen activator receptor, changes of24-hour blood pressure, and progression ofchronic kidney disease. J Am Heart Assoc 2021; 10 (1) e017225.
  • Tan X, Sundstrom J, Lind L, Franzon K., Kilander L, Benedict C. Reverse dipping of systolic blood pressure is associated with increased dementia risk in older men: A longitudinal study over 24 years. Hypertension 2021; 77 (4): 1383-1390.
  • Cuspidi C, Tadic M., Sala C, Carugo S., Mancia G, Grassi G. Reverse dipping and subclinical cardiac organ damage: a meta-analysis of echocardiographic studies. J Hypertens 2021; 39 (8) 1505-1512.
  • Di Raimondo D, Musiari G, Casuccio A. et al. Cardiac remodeling according to the nocturnal fall of blood pressure in hypertensive subjects: The Whole Assessment of Cardiac Abnormalities in Non-Dipper Subjects with Arterial Hypertension (Wacanda) Study. J Pers Med 2021; 11 (12) 1371.
  • Matteucci E, Consani C, Masoni M..C, Giampietro O. Circadian blood pressure variability in type 1 diabetes subjects and their nondiabetic siblings — influence of erythrocyte electron transfer. Cardiovascular Diabetology 2010; 9: 61.
  • Matteucci E, Delia Bartola L., Giampietro O. Differences in circadian time structure of diastolic blood pressure between diabetes mellitus and essential hypertension. Diabetology & metabolic syndrome 2012; 4 (1) 51.
  • Naliano S, Uchida K, Kigoshi T., Azukizawa S., Iwasaki R., Kanelio M, Morimoto S. Circadian rhythm ofblood pressure in normotensive NIDDM subjects. Its relationship to microvascular complications. Diabetes Care 1991; 14 (8): 707-711.
  • Naliano S, Fukuda M, Hotta F. et al. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes 1998; 47 (9) 1501-1506.
  • Nallano S, Ogihara M, Tamura C. et al. Reversed circadian blood pressure rhythm independently predicts endstage renal failure in non-insulin-dependent diabetes mellitus subjects. Journal of Diabetes & its Complications 1999; 13 (4) 224-231.
  • Kario K, Pickering T. G, Matsuo T., Hoshide S., Schwartz J.E., Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001; 38 (4) 852-857.
  • Kario K, Shimada K, Pickering T.G. Abnormal nocturnal blood pressure falls in elderly hypertension: clinical significance and determinants. Journal of Cardiovascular Pharmacology 2003; 41 (Suppl 1) S61-S66.
  • Kario K, Shimda K Risers and extreme-dippers ofnocturnal blood pressure in hypertension: antihypertensive strategy for nocturnal blood pressure. Clinical & Experimental Hypertension (New York) 2004; 26 (2) 177-189.
  • Maeda K, Yasunari K, Watanabe T., Nallamura M. Oxidative stress by peripheral blood mononuclear cells is increased in hypertensives with an extreme-dipper pattern and/or morning surge in blood pressure. Hypertension Research — Clinical & Experimental 2005; 28 (9) 755-761.
  • Hamada T., Murata T., Narita K. et al. The clinical significance of abnormal diurnal blood pressure variation in healthy late middle-aged and older adults. Blood Pressure 2008; 17 (3): 134-140.
  • Ishikawa J, Shimizu M, Hoshide S. et al. Cardiovascular risks of dipping status and chronic kidney disease in elderly Japanese hypertensive patients. Journal of Clinical Hypertension 2008; 10 (10) 787-794.
  • Palatini P, Vwdecchia P, Beilin L.J. et al. Association ofextreme nocturnal dipping with cardiovascular events strongly depends on age. Hypertension 2020; 75 (2) 324-330.
  • Cardoso C.R.L., Salles G.F. Associations of the nocturnal blood pressure fall and morning surge with cardiovascular events and mortality in individuals with resistant hypertension. Journal ofHypertension 2021; 39 (6) 1177-1187.
  • Cohen D.L., Townsend R.R. Is it morning blood pressure surge or extreme nocturnal dipping that accounts for the increased stroke risk in the morning waking hours? Journal of Clinical Hypertension 2014; 16 (12) 847.
  • Gorcan A, Argan O, Avci E. et al. A new risk factor for predicting stroke in patients with atrial fibrillation: morning blood pressure surge. Blood Pressure Monitoring 2023; 28 (2) 73-78.
  • Zhang H, Cui Y, Zhao Y. et al. Association of circadian rhythm of blood pressure and cerebral small vessel disease in community-based elderly population. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 2019; 74 (8) 1322-1330.
  • Otsuka K, Cornelissen G, Halberg F. Predictive value ofblood pressure dipping and swinging with regard to vascular disease risk. Clinical Drug Investigation 1996; 11: 20-31.
  • Otsuka K, Cornelissen G, Halberg F., Oehlert G. Excessive circadian amplitude of blood pressure increases risk of ischemic stroke and nephropathy. J Medical Engineering & Technology 1997; 21: 23-30.
  • Mackenzie I.S, Rogers A, Poulter N.R. et al. TIME Study Group. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study) a prospective, randomised, open-label, blinded-endpoint clinical trial. The Lancet 2022; 400: 1417-1425.
  • Bowles N.P., Thosar S.S., Herzig M.X., Shea S.A. Chronotherapy for Hypertension. Curr Hypertens Rep 2018; 20 (11) 97.
  • Wang C., Ye Y., Liu C, Zhou Y., Lv L., Cheng C., Li S, Lou T., Liu X. Evening versus morning dosing regimen drug therapy for chronic kidney disease patients with hypertension in blood pressure patterns: a systematic review and meta-analysis. Intern Med J 2017; 47 (8) 900-906.
  • Stranges P.M., Drew A.M., Rafferty P., Shuster J.E., Brooks A.D. Treatment of hypertension with chronotherapy: is it time of drug administration? Ann Pharmacother 2015; 49 (3) 323-334.
  • Chiriaco M., Sacchetta L., Forotti G. et al. Prognostic value of 24-hour ambulatory blood pressure patterns in diabetes: A 21-year longitudinal study. Diabetes, Obesity & Metabolism 2022; 24 (11) 2127-2137.
  • WangC., YeZ., LiY. etal. Prognostic value ofreverse dipper blood pressure pattern in chronic kidney disease patients not undergoing dialysis: Prospective cohort study. Scientific Reports 2016; 6: 34932.
  • Melgarejo J.D., Lee J.H., Petitto M. et al. Glaucomatous Optic Neuropathy Associated with Nocturnal Dip in Blood Pressure: Findings from the Maracaibo Aging Study. Ophthalmology 2018; 125 (6) 807-814.
  • Kario K., Schwartz J.E., Pickering T.G. Ambulatory physical activity as a determinant of diurnal blood pressure variation. Hypertension 1999; 34 (4 Pt 1): 685-691.
  • Zhao S., Fu S., Ren J, Luo L. Poor sleep is responsible for the impaired nocturnal blood pressure dipping in elderly hypertensive: A cross-sectional study of elderly. Clinical & Experimental Hypertension (New York) 2018; 40 (6): 582-588.
  • Otsuka K., Watanabe H., Cornelissen G., Shinoda M., Uezono K., Kawasaki T., Halberg F. Gender, age and circadian blood pressure variation of apparently healthy rural vs. metropolitan Japanese. Chronobiologia 1990; 17: 253-265.
  • Salles G.F., Reboldi G., Fagard R.H. etal. Prognostic effect ofthe nocturnal blood pressure fall in hypertensive patients: The Ambulatory Blood Pressure Collaboration in Patients With Hypertension (ABC-H) Meta--Analysis. Hypertension 2016; 67 (4) 693-700.
  • Cuspidi C., Meani S., Salerno M. et al. Reproducibility of nocturnal blood pressure fall in early phases of untreated essential hypertension: a prospective observational study. Journal ofHuman Hypertension 2004; 18 (7) 503-509.
  • Sackett Lundeen L., Otsuka K., Havelkova A. et al. From self-surveillance in schools and monitoring in the experimental laboratory to vascular variability disorders. World Heart Journal 2021; 13 (1): 25-27.
  • Stergiou G., Brunstr^m M., MacDonald T. etal. Bedtime dosing ofantihyperten-sive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension. J Hypertens 2022; 40: 1847-1858.
  • Kakaletsis N., Ntaios G., Milionis H., Karagiannaki A. etal. Midday dipping and circadian blood pressure patterns in acute ischemic stroke. Journal of Clinical Medicine 2023; 12 (14) 4816.
  • Watanabe M., Hida A., Kitamura S. etal. Rhythmic expression ofcircadian clock genes in human leukocytes and beard hair follicle cells. Biochem Biophys Res Commun 2012; 425 (4) 902-907.
  • Lewy A.J., Cutler N.L., Sack R.L. The endogenous melatonin profile as a marker for circadian phase position. J Biol Rhythms 1999; 14 (3) 227-236.
  • Horne J.A., Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol 1976; 4 (2) 97-110.
  • Roenneberg T., Wirz-Justice A., Martha Merrow M. Life between clocks: daily temporal patterns of human chronotypes. Journal of biological rhythms 2003; 18 (1) 80-90.
  • Baidoo V.A., Knutson K. Associations between circadian disruption and car-diometabolic disease risk: A review. Obesity 2023; 31 (3) 615-624.
  • Gupta N.J. Lifestyle and Circadian Health: Where the Challenges Lie? Nutr Metab Insights 2019; 12: 1178638819869024.
  • Culver M.N., McMillan N.K., Cross B.L. et al. Sleep duration irregularity is associated with elevated blood pressure in young adults. Chronobiology International 2022; 39 (10) 1320-1328.
  • Gamboa Madeira S., Reis C., Paiva T. et al. Social jetlag, a novel predictor for high cardiovascular risk in blue-collar workers following permanent atypical work schedules. Journal of Sleep Research 2021; 30 (6): e13380.
  • Hatori M., Hirota T. Cell-based phenotypic screens to discover circadian clock-modulating compounds. Methods in Molecular Biology 2022; 2482: 95-104.
  • Rasmussen E.S., Takahashi J.S., Green C.B. Time to target the circadian clock for drug discovery. Trends Biochem Sci 2022; 47 (9): 745-758.
  • Cornelissen G., Hirota T. Quo vadis. In: Chronobiology and Chronomedicine: From Molecular and Cellular Mechanisms to Whole Body Interdigitating Networks. Cornelissen G, Hirota Y (Eds.) Royal Society of Chemistry 2023; in press.
  • Tamura K.., Kohno L, Saito Y., ... Halberg F. Antihypertensive individualized therapeutic strategy. Difesa Sociale 1991; 6: 109-124.
  • Cornelissen G., DelcourtA., ToussaintG., ... HalbergF. Opportunity ofdetecting pre-hypertension: worldwide data on blood pressure overswinging. Biomed & Pharmacother 2005; 59 (Suppl 1): S152-S157.
Еще
Статья научная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp